• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【药物名称】L-692429

【化学名称】3-Amino-3-methyl-N-[2-oxo-1-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-2,3,4,5-tetrahydro-1H-1-benzazepin-3(R)-yl]butyramide

【CA登记号】145455-23-8, 145457-42-7 (HCl), 145455-80-7 (monotrifluoroacetate), 145456-71-9 (trifluoroacetate)

【 分 子 式 】C29H31N7O2

【 分 子 量 】509.61612

【开发单位】Merck & Co. (Originator)

【药理作用】ENDOCRINE DRUGS, Pituitary Disorder Therapy, Treatment of Growth Hormone Deficiency, Treatment of Growth Hormone Secretion Disorders, GHS Receptor Antagonists

合成路线1

A synthesis of L-692429 has been reported: The cyclization of isobutene (I) with chlorosulfonyl isocyanate (II) gives 1-(chlorosulfonyl)-4,4-dimethylazetidin-2-one (III), which is condensed with 3(R)-amino-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one (IV) by means of triethylamine in methanol to yield 3-methyl-3-(methylsulfonamido)-N-[2-oxo-2,3,4,5-tetrahydro-1H-1-benzaze pin-3(R)-yl]butyramide (V). The reaction of (V) with 2'-[1-(triphenylmethyl)tetrazol-5-yl]biphenyl-4-ylmethyl bromide (VI) by means of NaH in THF/DMF affords protected L-692429, which is finally deprotected by a treatment with 5N HCl.

1 Bergan, J.J.; Reider, P.J.; McNamara, J.M.; Volante, R.P.; Bhupathy, M.; A convergent synthesis of a novel non-peptidyl growth hormone secretagogue, L-692,429. Tetrahedron Lett 1995, 36, 52, 9445.
2 Schoen, W.R.; et al.; A novel 3-substituted benzazepinone growth hormone secretagogue (L-692,429). J Med Chem 1994, 37, 7, 897.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 15926 2-methyl-1-propene; isobutylene 115-11-7 C4H8 详情 详情
(II) 14101 Chlorosulfonyl isocyanate 1189-71-5 CClNO3S 详情 详情
(III) 15928 2,2-dimethyl-4-oxo-1-azetanesulfonyl chloride C5H8ClNO3S 详情 详情
(IV) 15929 (3R)-3-amino-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one C10H12N2O 详情 详情
(V) 15930 3-methyl-3-[(methylsulfonyl)amino]-N-[(3R)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl]butanamide C16H23N3O4S 详情 详情
(VI) 15538 5-[4'-(bromomethyl)[1,1'-biphenyl]-2-yl]-2-trityl-2H-1,2,3,4-tetraazole 124750-51-2 C33H25BrN4 详情 详情
(VII) 15932 3-methyl-3-[(methylsulfonyl)amino]-N-((3R)-2-oxo-1-[[2'-(1-trityl-1H-1,2,3,4-tetraazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl)butanamide C49H47N7O4S 详情 详情

合成路线2

The cyclization of benzonitrile (I) with sodium azide by means of ZnCl2 in hot DMF gives 5-phenyltetrazole (II), which is condensed with trityl chloride (III) by means of TEA in THF to yield 5-phenyl-2-(triphenylmethyl)tetrazole (IV). The condensation of (IV) with 4-iodotoluene (V) by means of n-BuLi, ZnCl2, (PPh3)2NiCl2 and CH3MgCl in THF affords 5-(4'-methylbiphenyl-2-yl)-2-triphenylmethyltetrazole ?VI), which is finally brominated with N-bromosuccinimide (NBS) and AIBN in refluxing acetic acid to provide the target intermediate 5-[4'-(bromomethyl)biphenyl-2-yl]-2-(triphenylmethyl)tetrazole (VII).

1 Fisher, M.H.; Wyvratt, M.J.; Schoen, W.R.; DeVita, R.J. (Merck & Co., Inc.); Benzo-fused lactams promote release of growth hormone. EP 0513974; JP 1994172316; US 5206235; WO 9216524 .
2 Anderson, R.K.; King, A.O.; Shuman, R.F. (Merck & Co., Inc.); Ortho-lithiation process for the synthesis of 2-substd. 1-(tetrazol-5-yl)benzenes. US 5039814 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 25904 benzonitrile 100-47-0 C7H5N 详情 详情
(II) 36353 5-phenyl-2H-1,2,3,4-tetraazole 18039-42-4 C7H6N4 详情 详情
(III) 28630 Triphenylchloromethane; 1-[Chloro(diphenyl)methyl]benzene; Trityl chloride 76-83-5 C19H15Cl 详情 详情
(IV) 36354 5-phenyl-2-trityl-2H-1,2,3,4-tetraazole C26H20N4 详情 详情
(V) 46620 1-iodo-4-methylbenzene C7H7I 详情 详情
(VI) 46621 5-(4'-methyl[1,1'-biphenyl]-2-yl)-2-trityl-2H-1,2,3,4-tetraazole C33H26N4 详情 详情
(VII) 15538 5-[4'-(bromomethyl)[1,1'-biphenyl]-2-yl]-2-trityl-2H-1,2,3,4-tetraazole 124750-51-2 C33H25BrN4 详情 详情

合成路线3

The selective monoesterification of 2,2-dimethylsuccinic acid (VIII) with methanol and sulfuric acid gives 2,2-dimethylsuccinic acid 4-methyl ester (IX), which is submitted to degradation with diphenylphosphoryl azide, TEA and benzyl alcohol in refluxing benzene, yielding 3-(benzyloxycarbonylamino)-3-methylbutyric acid methyl ester (X). The hydrolysis of (X) with NaOH in methanol affords the corresponding butyric acid (XI). The hydrogenation of 3-azido-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one (XII) with H2 over Pt/C in methanol gives the racemic 3-amino derivative (XIII), which is submitted to optical resolution by crystallization of the L-tartrate salt, yielding the 3(R)-amino derivative (XIV). The condensation of amine (XIV) with acid (XI) by means of benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate (BTPF) and DIEA in dichloromethane affords the corresponding amide (XV), which is condensed with the tetrazole derivative (VII) by means of NaH in DMF to provide the protected adduct (XVI). Finally, this compound is deprotected by hydrogenation with H2 over Pd/C in methanol and a treatment with TFA.

1 Watthey, J.W.; et al.; Synthesis and biological properties of (carboxyalkyl)amino-substituted bicyclic lactam inhibitors of angiotensin converting enzyme. J Med Chem 1985, 28, 10, 1511.
2 Fisher, M.H.; Wyvratt, M.J.; Schoen, W.R.; DeVita, R.J. (Merck & Co., Inc.); Benzo-fused lactams promote release of growth hormone. EP 0513974; JP 1994172316; US 5206235; WO 9216524 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VII) 15538 5-[4'-(bromomethyl)[1,1'-biphenyl]-2-yl]-2-trityl-2H-1,2,3,4-tetraazole 124750-51-2 C33H25BrN4 详情 详情
(VIII) 46622 2,2-dimethylsuccinic acid C6H10O4 详情 详情
(IX) 46623 4-methoxy-2,2-dimethyl-4-oxobutyric acid C7H12O4 详情 详情
(X) 46624 methyl 3-[[(benzyloxy)carbonyl]amino]-3-methylbutanoate C14H19NO4 详情 详情
(XI) 46625 3-[[(benzyloxy)carbonyl]amino]-3-methylbutyric acid C13H17NO4 详情 详情
(XII) 20891 3-azido-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one C10H10N4O 详情 详情
(XIII) 46628 3-amino-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one C10H12N2O 详情 详情
(XIV) 15929 (3R)-3-amino-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one C10H12N2O 详情 详情
(XV) 46626 benzyl 1,1-dimethyl-3-oxo-3-[[(3R)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl]amino]propylcarbamate C23H27N3O4 详情 详情
(XVI) 46627 benzyl 1,1-dimethyl-3-oxo-3-[((3R)-2-oxo-1-[[2'-(2-trityl-2H-1,2,3,4-tetraazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl)amino]propylcarbamate C56H51N7O4 详情 详情
Extended Information